Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Banyan Biomarkers
San Diego, California, United Statesbiomerieux.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Banyan Biomarkers developed and commercialized the first FDA-cleared blood test to aid in the evaluation of mild traumatic brain injury. The Brain Trauma Indicator measures levels of UCH-L1 and GFAP proteins released into blood after head trauma, providing a rapid, objective tool to help rule out intracranial lesions visible on CT scan. In a pivotal study with nearly two thousand patients, it predicted presence or absence of CT-detectable lesions with high accuracy (>97% sensitivity; >99% specificity). The company also offers preclinical/clinical sample analysis services using its proprietary biomarker panels for neurological and organ toxicity research.
- Therapeutic areas
- OtherNeurology
- Modalities
- Diagnostic test (Enzyme linked immunosorbent assay)Antibody (for detection of protein biomarkers)Device (in vitro diagnostic device)
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
bioMérieux – partnership to develop and market blood-based biomarkers for TBI diagnosis worldwideU.S. Department of Defense – major funding partner/collaborator on TBI diagnostics development contracts ($26.3 million contract awarded)
Beyond the preview
Go deeper on Banyan Biomarkers.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Banyan Biomarkers.